- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Multibillion Spent on Drug Development, But Is It Helping?
While the pharmaceutical industry has always justified the billions spent on developing a candidate drug molecule, the process has definitely seen some important changes. This article evaluates whether these revolutionary changes have influenced drug development for the better.
In November 2014, Tufts Center for Drug Discovery announced it takes $2.6 billion to push a drug through development and marketing approval—a process that often spans longer than 10 years.
This eye-opening amount of time and money was, of course, met with some skepticism from consumer groups and the media, which argued that the Tufts research—partially funded by drug makers—could simply be trying to justify rising drug prices. (Both The Wall Street Journal blog and The New York Times published pieces highlighting the ways critics approached the news release.)
But critics aside, it’s figures such as these that are inspiring the industry to find new ways to speed drug development. The solutions will vary depending on the type of treatment and the resources available to the companies developing these drugs.
Read the complete article at Bioprocess Online: http://bit.ly/1BSzJJB
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
